Remove Immunization Remove Pharmaceutical Companies Remove Specialty Pharmacies
article thumbnail

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. So, the pharmaceutical companies then pushed to get their 505(b)(2) drugs declared sole source,” Soefje said. “If This went into effect in January 2022.”

FDA 65
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How much is Rinvoq (upadacitinib) without insurance?

The Checkup by Singlecare

Rinvoq is classified in a group of drugs called Janus kinase inhibitors, or JAK inhibitors, and works by decreasing the activity of a specific part of the immune system. The pharmaceutical company AbbVie, Inc. You may be required to purchase Rinvoq at a specialty pharmacy. Food and Drug Administration in 2019.

article thumbnail

Is Belantamab Mafodotin Making a Comeback?

Pharmacy Times

4,5 DREAMM-7 In DREAMM-7, patients with RRMM who had received at least 1 prior line of therapy were randomized 1:1 to receive belantamab mafodotin plus bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies) and dexamethasone (BVd) compared with daratumumab (Darzalex; Johnson & Johnson), bortezomib, and dexamethasone (DVd).

article thumbnail

Stelara generic availability, cost, and more

The Checkup by Singlecare

It is made by the pharmaceutical company Amgen, Inc. In April of 2024, the FDA approved Selarsdi (ustekinumab-aekn), a Stelara biosimilar made by the pharmaceutical companies Alvotech and Teva Pharmaceuticals. Wezlana (ustekinumab-auub) was FDA approved on Oct. 31, 2023, as an interchangeable biosimilar to Stelara.

FDA 52
article thumbnail

Stelara for psoriasis: Dosage, efficacy & more

The Checkup by Singlecare

It is a biologic medication and monoclonal antibody made by the pharmaceutical company Janssen Biotech. Stelara works by blocking proteins in the immune system that cause inflammation. Stelara as a treatment for psoriasis People with psoriasis have an overactive immune system. every eight weeks.

Dosage 98
article thumbnail

Avsola vs. Remicade: Differences, similarities & side effects

The Checkup by Singlecare

Avsola vs. Remicade: Key differences Remicade, made by the pharmaceutical company Janssen Biotech, was approved by the Food and Drug Administration (FDA) in 1998. In some cases, Avsola and Remicade may be filled at a specialty pharmacy. Continue reading to learn more about Avsola and Remicade.